S

Somerset Skin Centre | Derm Center

Research site
(Unclaimed)
Location
255 Kirts Boulevard, Troy, Michigan, United States of America
Site insights

Top conditions

Psoriasis (16 trials)

Dermatitis (10 trials)

Atopic Dermatitis (10 trials)

Eczema (9 trials)

Acne Vulgaris (4 trials)

Top treatments

Lebrikizumab
LY3471851
PF-04965842
Adalimumab
Rocatinlimab
Guselkumab
Azelaic acid
Pf-04965842
CNTO 1959
AMG 451

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 32
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

The co-primary objectives of the study are to:Evaluate the efficacy of rocatinlimab compared with placebo at Week 24, assessed using Validated Invest...

Active, not recruiting
Atopic Dermatitis
Other: Placebo
Drug: Rocatinlimab

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.

Enrolling
Atopic Dermatitis
Drug: Rocatinlimab
Other: Placebo

The purpose of this study is to evaluate the efficacy of guselkumab treatment versus placebo in skin of color participants with predominant moderate-...

Active, not recruiting
Scalp Psoriasis
Plaque Psoriasis
Drug: Guselkumab
Drug: Placebo
Locations recently updated

B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...

Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 100 mg
Drug: Placebo

Trial sponsors

LEO Pharma logo

LEO Pharma (5 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems